2 legendary ASX large-cap shares trading on hard-to-ignore valuations

These large stocks look good value to me.

| More on:
A woman stands on a huge oversized wooden park bench with her arms outstretched towards the mountainous horizon in the distance.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX large-cap shares can be great investments due to their strong position in their industry and ability to deliver large profits.

With the S&P/ASX 200 Index (ASX: XJO) regularly hitting new all-time highs, it may be difficult to find investments that seem attractively priced.

But, there are a few areas of the market that look appealing.

I'm going to discuss two ASX large-cap shares that have seen their share prices decline over the past year, but their futures look promising.

Sonic Healthcare Ltd (ASX: SHL)

Sonic is a large, global pathology business with a presence in countries such as Australia, the USA, Germany, the UK, Switzerland and so on.

Over the past year, Sonic Healthcare's share price has fallen by 12%, compared to a 12% rise for the ASX 200.

It's understandable why the company has fallen due to a few factors, including inflation of costs and the loss of COVID-19 testing revenue.

But, I believe there are a number of positives that can help the company over the long-term. I'll mention a few of them now.

Sonic has made several acquisitions in Europe, particularly in Switzerland and Germany, to enhance its scale and presence in those regions. Sonic is currently working on unlocking synergies.

The ASX large-cap share has made equity investments in AI businesses, with those AI services potentially capable of improving Sonic's service and efficiencies.  

The last thing I'll point to is the ongoing solid organic base business revenue growth – in FY24 the growth rate was 6%.

According to the estimates on Commsec, the Sonic Healthcare share price is valued at under 22x FY26's estimated earnings with a forecast dividend yield of 4% (excluding franking credits).

Rio Tinto Ltd (ASX: RIO)

ASX iron ore shares can be opportunities when there is a significant weakness regarding the iron ore price. In 2024 to date, the Rio Tinto share price is down close to 20%.

Commodities can be cyclical opportunities if we buy when prices are low (and possibly sell when prices are higher).

There is no financial rule to say when the next rebound of the iron ore price will be, or by how much the price will rise.

However, there are some optimistic signs of a potential turnaround with President Xi Jinping urging China to strive to "achieve its annual economic and social development goals and tasks", raising market hopes for further stimulus, according to Trading Economics. It's also possible that China may soon cut interest rates for trillions of dollars of mortgages.

I'm also attracted to Rio Tinto's efforts to grow its copper exposure, which could be one of the most important commodities in the coming years because of its usage in things like electric vehicles and renewable energy.

The ASX large-cap share is valued at 10x FY26's estimated earnings with a possible fully franked dividend yield of 5.7% in FY26.

Motley Fool contributor Tristan Harrison has positions in Sonic Healthcare. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Blue Chip Shares

2 strong blue chip ASX 200 shares to buy with $20,000

Let's see why analysts think these top stocks could be buys.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Blue Chip Shares

Should you buy, hold, or sell CBA, Fortescue, and Woolworths shares?

One broker has given its verdict on these blue chips.

Read more »

Happy man working on his laptop.
Blue Chip Shares

3 ASX blue chips to buy before earnings season

Analysts recently named these shares as buys. Let's see what they are recommending.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

2 of the best ASX 200 blue chip shares to buy now

Bell Potter sees these as the creme de la creme right now.

Read more »

Person holding a blue chip.
Opinions

Buy alert! 2 ASX 200 blue-chip shares worth a look now: expert

Dylan Evans from Catapult Wealth has identified two blue-chip shares that he thinks are good buys today.

Read more »

A group of young friends celebrating and toasting with beers
Blue Chip Shares

This beaten-down ASX 200 stock could be a turnaround story

Let's see if analysts think this stock is a buy after its heavy decline.

Read more »

A young woman sits on a sofa in a stylish home with her laptop computer balanced on her knee and smiles with a satisfied look on her face at what she's seeing on the screen.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These stocks could provide strong passive income.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

3 ASX 200 blue chip shares to buy with $3,000 in July

Analysts have recently named these well-known stocks as top buys.

Read more »